Bioptik Technology Incorporation (TPEX:4161)
23.10
+0.10 (0.43%)
Aug 26, 2026, 11:16 AM CST
TPEX:4161 Revenue
Bioptik Technology Incorporation had revenue of 237.60M TWD in the quarter ending June 30, 2026, with 24.73% growth. This brings the company's revenue in the last twelve months to 912.86M, up 10.76% year-over-year. In the year 2025, Bioptik Technology Incorporation had annual revenue of 837.19M, down -3.25%.
Revenue (ttm)
912.86M
Revenue Growth
+10.76%
P/S Ratio
1.51
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.38B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 837.19M | -28.14M | -3.25% |
| Dec 31, 2024 | 865.34M | 36.83M | 4.45% |
| Dec 31, 2023 | 828.50M | 60.75M | 7.91% |
| Dec 31, 2022 | 767.75M | 29.86M | 4.05% |
| Dec 31, 2021 | 737.89M | 252.29M | 51.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.78B |
| Cowealth Medical Holding | 2.86B |
| OK Biotech | 1.54B |
| Dynamic Medical Technologies | 1.40B |
| AViTA | 972.61M |
| Diamond Biotechnology | 464.63M |
| Wiltrom | 314.09M |
| Taiwan Biomaterial | 182.32M |